Oncology Xagena
The presence of only five tiny strands of RNA is enough to clearly distinguish cancerous thyroid tissue from otherwise normal tissue. The findings provide more evidence that an emerging set of RNA ...
Study results have provided further valuable insights into certain genetic mutations which occur in childhood thyroid tumours and their link to both radiation exposure and patient age. The unique ...
A multicenter international study has found that after surgery for thyroid cancer, giving genetically engineered human thyroid-stimulating hormone ( rhTSH ) before radioiodine treatment avoids the pre ...
A multicenter international study has found that after surgery for thyroid cancer, giving genetically engineered human thyroid-stimulating hormone ( rhTSH ) before radioiodine treatment avoids the pre ...
A multicenter international study has found that after surgery for thyroid cancer, giving genetically engineered human thyroid-stimulating hormone ( rhTSH ) before radioiodine treatment avoids the pre ...
AstraZeneca announced today that it has withdrawn the regulatory submissions for the use of ZACTIMA ( Vandetanib ) 100mg in combination with chemotherapy in patients with advanced non-small cell lung ...
A medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from Mayo Clinic indicates. At the annual meeting ...
Pregnant women appear to have worse clinical and economic outcomes after thyroid and parathyroid surgery compared with women who are not pregnant, according to a report in the May issue of Archives of ...
In a study of patients undergoing thyroid surgery performed by a single surgeon, older adults did not appear to have more complications than younger patients, according to a report in October issue of ...
Individuals with papillary thyroid cancer that has not spread beyond the thyroid gland appear to have favorable outcomes regardless of whether they receive treatment within the first year after diagno ...
People living in volcanic areas may be at a higher risk for thyroid cancer.The increasing incidence of thyroid cancer has been attributed to more sensitive screening, but recent evidence indicates tha ...
A medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer.At the annual meeting of the American Society of Clinical O ...
The cancer drug Sorafenib ( Nexavar ) holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial.If approved for use in thyroid ...
Bayer HealthCare and Onyx Pharmaceuticals, have announced that the FDA ( Food and Drug Administration ) has approved the oral multi-kinase inhibitor Nexavar ( Sorafenib ) for the treatment of patients ...
Eisai has announced that the phase III SELECT trial ( Study 303 ) of Lenvatinib, an investigational selective tyrosine kinase inhibitor ( TKI ) with a novel binding mode, the first-in-class of its kin ...
